Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001040790 | SCV001204380 | uncertain significance | Neuronal ceroid lipofuscinosis | 2019-12-11 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine with arginine at codon 134 of the CLN3 protein (p.Cys134Arg). The cysteine residue is weakly conserved and there is a large physicochemical difference between cysteine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with juvenile neuronal ceroid lipofuscinoses (PMID:21990111). ClinVar contains an entry for this variant (Variation ID: 56268). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049680 | SCV000082087 | probable-pathogenic | Neuronal ceroid lipofuscinosis 3 | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |